G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

Manufacturing Strategy Associate

Full-Time
No salary listed
Senior
Bachelor's, Master's
Chalfont St Giles, Chalfont Saint Giles, UK+1 moreMore locations: Cork, Ireland
HybridHybrid work is indicated by the posting.
Business & StrategyCorporate Strategy

About the job

Requirements
  • A bachelor's degree in Supply Chain Management, Operations Management, Industrial Engineering, or a related field is required.
  • Five to seven years of experience in manufacturing operations, supply chain, engineering, or manufacturing strategy roles within a regulated industry is required.
  • Understanding of manufacturing operations and capacity planning is required.
  • Experience working across global, cross-functional teams and influencing without direct authority is required.
  • Experience with business cases and financial acumen is required.
  • Working knowledge of Lean, Six Sigma, and continuous improvement frameworks is required.
  • Strong communication and presentation skills are required, including the ability to convey complex analyses and strategic insights clearly to senior leaders.
  • A master's degree is preferred.
  • Experience with sterile, aseptic, or highly regulated manufacturing environments is advantageous.
Responsibilities
  • Support the development and execution of global manufacturing, capacity, and resiliency strategies aligned with long-term business objectives and customer needs.
  • Translate manufacturing strategy into clear roadmaps, initiatives, and milestones across sites and functions.
  • Collaborate with manufacturing sites, engineering, and supply chain teams to identify current- and future-state capacity requirements.
  • Support the development and evaluation of strategic business cases for manufacturing network design, capacity expansion, and resiliency initiatives, including cost-benefit and risk trade-off analyses.
  • Contribute to make-or-buy assessments and manufacturing footprint decisions for new product introductions, vertical integration, and external supply opportunities.
  • Provide analytical input and data-driven insights to support recommendations on manufacturing locations and investment prioritization.
  • Support the definition, tracking, and governance of key performance indicators and metrics related to manufacturing capacity, utilization, resilience, and financial performance.
  • Apply Lean, Six Sigma, and continuous improvement methodologies to identify opportunities for cost reduction, waste elimination, and resource optimization.
  • Monitor initiative progress and prepare clear, structured updates and materials for senior leadership review.
  • Support change management efforts associated with manufacturing strategy initiatives, including stakeholder engagement, communication, and adoption.
  • Ensure manufacturing strategy and capacity initiatives align with applicable regulatory, quality, and safety requirements.
  • Promote compliance, patient focus, and operational excellence across all initiatives.
Desired Qualifications
  • Strong analytical and problem-solving skills with the ability to translate data into insights.
  • Learning agility and comfort operating in evolving and ambiguous environments.
  • Effective collaboration, influencing, and stakeholder engagement skills.
  • Execution-focused approach with attention to detail and follow-through.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.

Associated Press
Sep 22nd, 2026
GE HealthCare raises quarterly dividend 14% to $0.04 per share for Q3 2026

GE HealthCare Technologies announced a 14% dividend increase for the third quarter of 2026. The company's board declared a cash dividend of $0.04 per share, up from the previous quarter. The dividend will be paid on 13 November 2026 to shareholders of record as of 23 October 2026. GE HealthCare is a global healthcare solutions provider specialising in medical technology, pharmaceutical diagnostics, and AI-enabled software solutions. The company operates a $20.6 billion business with approximately 54,000 employees worldwide, serving the healthcare industry through its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments.

Yahoo Finance
Sep 15th, 2026
GE HealthCare launches AI tool to forecast hospital capacity bottlenecks 72 hours ahead

GE HealthCare has launched CareIntellect for Operations, an AI-powered software application that helps health systems forecast capacity constraints up to 72 hours ahead. The solution analyses hundreds of patient and operational data points to predict bottlenecks and recommend actions to optimise capacity and throughput. The Queen's Health Systems and Duke Health will be the first to implement the application. It uses two proprietary AI models: the Pressure Forecast model, which predicts resource constraints across hospitals and departments, and the Estimated Day of Discharge model, which predicts when patients will be discharged. The tool addresses operational challenges as US inpatient volumes rose 5.3% in 2025, requiring health systems to manage increased demand whilst facing staffing shortages and rising costs.

Yahoo Finance
Sep 1st, 2026
GE HealthCare secures CE mark for Photonova Spectra photon-counting CT system

GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.